Purchase Order 75N93022P00830

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,450.00 firm fixed price purchase order to Applied Stemcell, Inc. to investigate cellular dysfunction associated with hereditary mutation within the prion gene. The contractor must generate two homozygous clones with the E200K prion gene mutation removed and two clones without the mutation removed, validating pluripotency and gene sequence. This requirement...

This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company, for plasmid cloning and propagation services. The $11,409.96 contract is for work to be performed in Piscataway, New Jersey. Genscript, which specializes in gene synthesis, gene editing, and other molecular biology services, has received numerous prime and...

This is a $275,922 firm fixed-price purchase order contract awarded by the U.S. Department of Agriculture (USDA) to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California. The contract is for the development of novel gene-targeted mouse models to study livestock prion diseases in cattle, sheep, goats, cervids, and camels. The contract was awarded under a total small business set-aside solicitation, with the work to be performed at the contractor's laboratory facility...

This is a firm fixed price BPA call contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Transnetyx, Inc. to provide polymerase chain reaction (PCR) services for genotyping. The contract has a potential value of $13,958.40 and a completion date of March 13, 2025. Transnetyx is an automated genotyping company that has previously provided DNA extraction, multi-gene analysis, bioinformatics, and genotyping...

This is a firm fixed-price contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Transnetyx, Inc. for $5,000.00 to provide custom mouse genotyping services. The contract is a Blanket Purchase Agreement (BPA) call, meaning it is part of a larger indefinite delivery vehicle with the NIH, which allows for the procurement of these genotyping services on an as-needed basis to support the institute's...

This is a $26,650.70 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS) to Genewiz, LLC, a subsidiary of Azenta, Inc. The contract is for custom cloning and lentiviral preparation services to support the development of assays and therapeutics for NGYL1 disease within NCATS' Therapeutic Development Branch. The work includes gene cloning, lentiviral vector preparation, and generation of lentiviral particles at high titer. This contract has...

Genscript USA Incorporated will provide gene synthesis and vector ark cloning services to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under the terms of a $12,108 firm fixed price purchase order, Genscript will deliver the requested products and services between September 2023 and September 2024. As the prime contractor, Genscript will leverage its expertise...

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $17,000 firm fixed price purchase order to Genoway of France to provide services related to the injection of targeted embryonic stem cell blastocyst clones and other functions. The contract has a period of performance from March 28, 2016 through June 17, 2016 and will be carried out in France. No additional context was provided regarding the agency's programs or use of contract deliverables....

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...